Michael Robert Martin - Aug 9, 2021 Form 4 Insider Report for Aurinia Pharmaceuticals Inc. (AUPH)

Role: Chief Business Officer
Signature: /s/ Michael Robert Martin
Stock symbol: AUPH
Transactions as of: Aug 9, 2021
Transactions value $: -$80,050
Form type: 4
Date filed: 8/10/2021, 04:09 PM
Previous filing: Jul 29, 2021
Next filing: Aug 27, 2021

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	AUPH	Common Stock	Sale	-$80.1K	-5K	-2.36%	$16.01	207K	Aug 9, 2021	Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 21, 2021.
F2	The price in column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $16.00 to $16.04, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range.

Content

The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 21, 2021.

The price in column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $16.00 to $16.04, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range.